Peter Alexander, of msnbc's The Daily Rundown, talks to the director of Texas’ new task force on infectious disease, Dr. Brett Giroir, CEO of Texas A&M Health Science Center.
With the first U.S. case of Ebola diagnosed last week in Texas, we must acknowledge a stark reality: Infectious threats are merely an airline ticket away. Because of our global connectivity, an epidemic anywhere poses a risk everywhere. If the virus had to arrive on U.S. soil, however, in some ways Texas was the best place. Our state is on the front lines of disease prevention and containment, and we’re well equipped for the challenge.
Brett P. Giroir, M.D., CEO of Texas A&M Health Science Center, joins HuffPost Live to talk about the recent Ebola scare in the United States.
A severe pandemic would disrupt the United States far beyond health and mortality repercussions. High rates of illness ranging from 25 to 30 percent of the population would cripple crucial services, business activities, education and the movement of goods and services nationwide and globally — ultimately leading to severe economic and homeland security consequences.
Gerald Parker, D.V.M., Ph.D., vice president for public health preparedness and response at Texas A&M Health Science Center, was recently appointed to the Federal Emergency Management Agency (FEMA) National Advisory Council (NAC).
Dr. Gerald Parker, vice president for public health preparedness and response, offers a roadmap for managing the next Ebola, or any global public health threat, whether naturally occurring or a deliberate attack.
Vaccines are among the greatest achievements in the history of public health. However, past challenges with vaccine development processes and frequent shortages during times of need have highlighted the importance of more extensive and reliable manufacturing operations.